Arif Habib
Research Subjects
Arif Habib has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Arjumand Shah
Regional Research Institute of Unani Medicine, Naseembagh Campus-University of Kashmir, Srinagar, India
3 shared publicationsArsheed Iqbal
3 shared publicationsHuma Rafiq
Regional Research Institute of Unani Medicine, Naseembagh Campus-University of Kashmir, Srinagar, India
2 shared publicationsAfroza Jan
Department of Physiology, Government Unani Medical College, Ganderbal, J&K, India
1 shared publicationArjumand
Regional Research Institute of Unani Medicine, Naseembagh Campus, University of Kashmir, India
1 shared publicationAsma Afzal
Department of Unani Medicine, Regional Research Institute of Unani Medicine, Srinagar, J&K, India
1 shared publication
Latest Publications
- Open Access
- 5 October 2026
- Published by Springer Nature in Sleep Science and Practice
- Vol. 10 (1) , 40
Sustained therapeutic benefits of unani interventions in primary insomnia: clinical outcomes, biomarker modulation, and relapse analysis
- 5 October 2026
- Published by Springer Nature in Sleep Science and Practice
- Vol. 10 (1) , 40
Open AccessSustained therapeutic benefits of unani interventions in primary insomnia: clinical outcomes, biomarker modulation, and relapse analysis
- 23 November 2023
- Published by Sciencedomain International in Journal of Complementary and Alternative Medical Research
- Vol. 24 (4) , 38-48
Efficacy and Safety of Unani Formulation in Loss of Appetite
Aims and Objectives: Loss of appetite (LOA) impacts individual well-being and quality of life. It can contribute to weight loss and nutritional deficiencies, and associated poor healthcare outcomes, including increased mortality. This study presents the efficacy and safety of Unani pharmacopeia formulation. Habb-e-TurshMushtahi in loss of appetite (Anorexia). Study Design: Open-labelled, single arm, clinical trial. Materials and Methods: The study was conducted on 100 patients having the complaint of loss of appetite; Patients of either sex in the age group of 18 to 65years and decreased appetite with SNAC ≤14 were included in the study. The treatment was given for two weeks and safety assessment was done before and after end of treatment. P-value 0.05 was considered significant. Results: Females were almost double than men who were suffered with the disease. The considered parameters show a good response p < 0.05 after the intervention of Unani pharmacopoeial formulation in both genders. In case of safety parameters, no significance p>0.05 has been seen for pathological and biochemical investigations. Conclusion: The management for the loss of appetite can be easily treated with the unani drug which is effective for the rapid relief without any adverse effect.
- 23 November 2023
- Published by Sciencedomain International in Journal of Complementary and Alternative Medical Research
- Vol. 24 (4) , 38-48
Efficacy and Safety of Unani Formulation in Loss of Appetite
Aims and Objectives: Loss of appetite (LOA) impacts individual well-being and quality of life. It can contribute to weight loss and nutritional deficiencies, and associated poor healthcare outcomes, including increased mortality. This study presents the efficacy and safety of Unani pharmacopeia formulation. Habb-e-TurshMushtahi in loss of appetite (Anorexia). Study Design: Open-labelled, single arm, clinical trial. Materials and Methods: The study was conducted on 100 patients having the complaint of loss of appetite; Patients of either sex in the age group of 18 to 65years and decreased appetite with SNAC ≤14 were included in the study. The treatment was given for two weeks and safety assessment was done before and after end of treatment. P-value 0.05 was considered significant. Results: Females were almost double than men who were suffered with the disease. The considered parameters show a good response p < 0.05 after the intervention of Unani pharmacopoeial formulation in both genders. In case of safety parameters, no significance p>0.05 has been seen for pathological and biochemical investigations. Conclusion: The management for the loss of appetite can be easily treated with the unani drug which is effective for the rapid relief without any adverse effect.
- Open Access
- 29 August 2023
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 10 (9) , 3257-3263
Clinical study to evaluate the efficacy of Commiphora muku (Muqil) on thyroid function in hypothyroidism
Background: Hypothyroidism is a common endocrine disorder in which there is deficient production of thyroid hormone. Even though hormone replacement therapy is the mainstay treatment of hypothyroidism, but due to adverse effects on long term use, safe and effective Unani herbal drugs need to be researched. A decrease in serum concentrations of thyroid hormone causes an increased secretion of thyroid stimulating hormone (TSH), thus resulting in elevated serum TSH concentration. Methods: The methods used to determine thyroid dysfunction are still serum thyroid stimulating hormone and the main circulating thyroid hormones thyroxine and triiodothyronine either as total or estimated free concentrations, and it is indeed the improved assay sensitivities and specificities that have made it possible to diagnose these milder forms. TSH, T3 and T4 with safety parameters tests were done before treatment and after completion of treatment in both the groups in order to make the proper diagnosis, to exclude other systemic ailments and to assess the efficacy/safety of the proposed herbal drug. Results: The effects of test drug on lowering the raised serum TSH are attributed to the thyroid activities of the test drug which shoes highly significance p<0.01 before and after intervention. In respect of thyroxin there were no significant results between the test and control group. Conclusions: The study concluded that the efficacy of Commiphora mukul (Muqil) on thyroid function was designed to explore the role of Unani herbal drugs in the management of hypothyroidism on Unani principles is effective, safe and cost effective.
- 29 August 2023
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 10 (9) , 3257-3263
Open AccessClinical study to evaluate the efficacy of Commiphora muku (Muqil) on thyroid function in hypothyroidism
Background: Hypothyroidism is a common endocrine disorder in which there is deficient production of thyroid hormone. Even though hormone replacement therapy is the mainstay treatment of hypothyroidism, but due to adverse effects on long term use, safe and effective Unani herbal drugs need to be researched. A decrease in serum concentrations of thyroid hormone causes an increased secretion of thyroid stimulating hormone (TSH), thus resulting in elevated serum TSH concentration. Methods: The methods used to determine thyroid dysfunction are still serum thyroid stimulating hormone and the main circulating thyroid hormones thyroxine and triiodothyronine either as total or estimated free concentrations, and it is indeed the improved assay sensitivities and specificities that have made it possible to diagnose these milder forms. TSH, T3 and T4 with safety parameters tests were done before treatment and after completion of treatment in both the groups in order to make the proper diagnosis, to exclude other systemic ailments and to assess the efficacy/safety of the proposed herbal drug. Results: The effects of test drug on lowering the raised serum TSH are attributed to the thyroid activities of the test drug which shoes highly significance p<0.01 before and after intervention. In respect of thyroxin there were no significant results between the test and control group. Conclusions: The study concluded that the efficacy of Commiphora mukul (Muqil) on thyroid function was designed to explore the role of Unani herbal drugs in the management of hypothyroidism on Unani principles is effective, safe and cost effective.
- Open Access
- 10 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 7257052
Erratic Behavioral Attitude Leads to Noncommunicable Diseases: A Cross‐Sectional Study
Background. The burden of noncommunicable diseases (NCDs) in the Arab world has reached an alarming level. Behavioral risk factors including consumption of fast food, inadequate sleep, and skipping meals are pervasive. This study aims at establishing the association between NCDs and modernized behavioral risk factors among populations. Methods. A cross‐sectional study was carried out with 1070 respondents who were 18 years old. The data were collected using a structured questionnaire with the help of the WHO STEPS approach with some modifications regarding NCD risk factors. Results. 30% of respondents had cardiovascular diseases (CVD) followed by respiratory diseases (23%) and diabetes (3%) while the habit of smoking was found among 52% of respondents followed by physical inactivity (49%), skipping meals (24%), and inadequate sleep (30%). Consumption of fast food was found to be a significant risk factor for obesity (odds ratio (OR) = 2.72, 95% confidence interval (CI) [1.50, 4.92]), CVD (OR = 1.52, 95% CI [1.20, 1.94]), and respiratory disease (OR = 2.13, 95% CI [1.58, 2.86]). Significant linkages were found between CVD and smoking (OR = 0.69, 95% CI [0.54, 0.88]), diet pattern (OR = 1.86, 95% CI [1.44, 2.39]), fast food (OR = 1.52, 95% CI [1.20, 1.94]), and sleep hours (OR = 0.57, 95% CI [0.42, 0.79]). Conclusions. Undesirable behavioral risk factors pose a considerable threat to public health with a high prevalence rate of NCDs. Reducing the NCD burden and promoting healthy lifestyle formation of suitable strategies and their smooth implementation is the need of the hour.
- 10 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 7257052
Open AccessErratic Behavioral Attitude Leads to Noncommunicable Diseases: A Cross‐Sectional Study
Background. The burden of noncommunicable diseases (NCDs) in the Arab world has reached an alarming level. Behavioral risk factors including consumption of fast food, inadequate sleep, and skipping meals are pervasive. This study aims at establishing the association between NCDs and modernized behavioral risk factors among populations. Methods. A cross‐sectional study was carried out with 1070 respondents who were 18 years old. The data were collected using a structured questionnaire with the help of the WHO STEPS approach with some modifications regarding NCD risk factors. Results. 30% of respondents had cardiovascular diseases (CVD) followed by respiratory diseases (23%) and diabetes (3%) while the habit of smoking was found among 52% of respondents followed by physical inactivity (49%), skipping meals (24%), and inadequate sleep (30%). Consumption of fast food was found to be a significant risk factor for obesity (odds ratio (OR) = 2.72, 95% confidence interval (CI) [1.50, 4.92]), CVD (OR = 1.52, 95% CI [1.20, 1.94]), and respiratory disease (OR = 2.13, 95% CI [1.58, 2.86]). Significant linkages were found between CVD and smoking (OR = 0.69, 95% CI [0.54, 0.88]), diet pattern (OR = 1.86, 95% CI [1.44, 2.39]), fast food (OR = 1.52, 95% CI [1.20, 1.94]), and sleep hours (OR = 0.57, 95% CI [0.42, 0.79]). Conclusions. Undesirable behavioral risk factors pose a considerable threat to public health with a high prevalence rate of NCDs. Reducing the NCD burden and promoting healthy lifestyle formation of suitable strategies and their smooth implementation is the need of the hour.
- Open Access
- 19 July 2018
- Published by MedCrave Group Kft. in Biometrics & Biostatistics International Journal
- Vol. 7 (4) , 1
Determination of parametric average code length of inaccuracy measure
- 19 July 2018
- Published by MedCrave Group Kft. in Biometrics & Biostatistics International Journal
- Vol. 7 (4) , 1
Open AccessDetermination of parametric average code length of inaccuracy measure
- Open Access
- 12 February 2018
- Published by MedCrave Group Kft. in Biometrics & Biostatistics International Journal
- Vol. 7 (1) , 54-58
Some new results on fuzzy generalized ‘useful’ mean lengths and its bounds
In this paper, we propose a fuzzy generalized ‘useful’ parametric mean length and bounds are obtained in terms of useful fuzzy measure. The bounds obtained are new and some known results are the particular cases of the proposed measure and bounds.
- 12 February 2018
- Published by MedCrave Group Kft. in Biometrics & Biostatistics International Journal
- Vol. 7 (1) , 54-58
Open AccessSome new results on fuzzy generalized ‘useful’ mean lengths and its bounds
In this paper, we propose a fuzzy generalized ‘useful’ parametric mean length and bounds are obtained in terms of useful fuzzy measure. The bounds obtained are new and some known results are the particular cases of the proposed measure and bounds.